4//SEC Filing
Matthews Judith M. 4
Accession 0001209191-23-018585
CIK 0001659323other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 6:00 PM ET
Size
9.4 KB
Accession
0001209191-23-018585
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2023-03-11+6,666→ 11,018 total - Tax Payment
Ordinary Shares
2023-03-11$0.96/sh−2,883$2,768→ 8,135 total - Exercise/Conversion
Restricted Share Units
2023-03-11−6,666→ 0 total→ Ordinary Shares (6,666 underlying)
Footnotes (4)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
- [F3]Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs.
- [F4]On March 11, 2021, the reporting person was granted an award of 13,333 RSUs, 50% of which vested on March 11, 2022, with the remaining 50% having vested on March 11, 2023.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001734033
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 6:00 PM ET
- Size
- 9.4 KB